Analysis of cognitive functions after venlafaxyne treatment in post-stroke depression;Analisi dell'influenza del trattamento con venlafaxina sull'outcome cognitivo in pazienti con depressione post-stroke: Risultati di uno studio clinico randomizzato, controllato in doppio cieco

Nuova Rivista di Neurologia

Volumn 9, Issue 1, 1999, Pages 15-27

  Battaglia, Alessandro ^a   Bejor, Maurizio ^b   Petri, Maurizio ^a   Beumgarde, Dominique ^b   Bartalini, Brunella ^a  

^a Az USL 12   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

Cognitive functions; Depression; Rehabilitation; Stroke

Indexed keywords

VENLAFAXINE;

ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; HUMAN; RANDOMIZED CONTROLLED TRIAL; STROKE; TREATMENT OUTCOME;

EID: 0032816298     PISSN: 1122035X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (128)

1. Agrell B., Dehlin O.: Depression in stroke patients with left and right hemisphere lesions. Aging, 1994; 1: 49-56.
2. Andersen G., Vestergaard K., Riis J., Lauritzen L.: Incidence of post-stroke depression during the first year in a large unselected stroke population determined using a valid standardized rating scale. Acta Psychiatr. Scand., 1994; 90: 190-195.
3. Andersen G., Vestergaard K., Riis J., Lauritzen L.: Risk factors for post-stroke depression. Acta Psychiatr. Scand., 1995; 92: 193-198.
4. Andrews G., Stewart G., Morris-Yates A., et al.: Evidence for a general neurotic syndrome. Br. J. Psychiatry, 1990; 157: 6-12.
5. A.P.A.: Diagnostic and statistical manual for mental disorders. Fourth edition (DSM-IV), Washington D.C., 1994.
6. Astrom M., Adolfsson R., Asplund K.: Major depression in stroke patients: a 3-year longitudinal study. Stroke, 1995; 24 (7): 976-982.
7. Astrom M., Asplund K., Astrom T.: Psychosocial function and life satisfaction after stroke. Stroke, 1992; 23: 527-531.
8. Baddeley A.D.: Working memory. Science, 1992; 255: 556-559.
9. Baddeley A.D.: Verbal and visual subsystems of working memory. Curr. Biol., 1993; 3: 563-565.
10. Baron B.M., Ogden A.M., Siegel B.W., Stegeman J.: Rapid down regulation of -adrenoceptors by co-administration of desipramine and fluoxetine. Eur. J. Pharmacol., 1988; 154: 125-134.
11. Battaglia A.: Medicina riabilitativa. Ed. Rosini, Firenze, 1995.
12. Benkert O., Hackett D., Realini R.: A randomized double-blind comparison of a rapidly escalating dose of venlafaxine and imipramine in inpatients with depression and melanconia. Neuropsychopharmacology, 1994; 10: 1655.
13. Bertuccelli-Papi M.: Sulla nozione di contesto in riabilitazione. Riabilitazione e apprendimento, 1987; 7: 3.
14. Black K.J.: Diagnosis depression and stroke. South. Med. J., 1995: 88(7): 699-708.
15. Bloom F.E., Lazerson A.: Il cervello, la mente e il comportamento. Ed. Ciba Geigy, Milano, 1990.
16. Bolla-Wilson K., Robinson R.G., Starkstein S.E., Boston J., Price T.R.: Lateralization of dementia of depression in stroke patients. Am. J. Psychiatry, 1989; 146(5): 627-634.
17. Brott T.G., Adams H.P., Olinger C.P. et al.: Measurements of acute cerebral infarction: a clinical examination scale. Stroke, 1989; 19: 1497-1500.
18. Brott T.G., Haley E.G., Levy D.E. et al.: Urgent therapy for stroke. Stroke, 1992; 23: 632-640.
19. Brown E.B., Tietjen G.E., Deveshwar R.K.: Clinical stroke scales: an intra-and interscale evaluation. Neurology, 1990; 40S1: 352-355.
20. Bryer J.P., Starksein S.E., Votypka V., Parikh R.M., Price T.R., Robinson R.G.: Reduction of CSF monoamine metabolites in poststroke depression: a preliminary report. J. Neuropsychiatry Clin. Neurosci., 1992; 4: 440-442.
21. Cabeza R., Nyberg L.: Imaging cognition: an empirical review of PET studies with normal subjects. Journal of Cognitive Neuroscience, 1997; 9, 1: 1-26.
22. Carrieri P.B., Indaco A., et al.: Turbe dell'affettività in pazienti con l'ictus ischemico. Riabilitazione e Science Neurologiche, 1988; 4: 23-26.
23. Collin C., Wade D.T., Davies S., Home V.: The Barthel ADL Index: a reliability study. International Disability Studies, 1988; 10: 61-63.
24. Corbetta M., Miezin F.M., Dobmeyer S., Shulman G.L., Petersen S.: Attentional modulation of neural processing of shape, color and velocity in humans. Science, 1990; 248: 1556-1559.
25. Cornoldi C.: Processi neuropsicologici della memoria. Ptah, Suppl. Edit. a Riabilitazione ed Apprendimento, 1992; XII: 3.
26. Cummings J.L.: Depression and Parkinson's disease. Am. J. Psichiatry, 1992; 149: 443-454.
27. Currier M.B., Murray G.B.: Electroconvulsive therapy for post-stroke depressed geriatric patients. J. Neuropsychiatry Clin. Neurosci., 1992; 4: 140-144.
28. Damasio A.R.: L'errore di Cartesio - Emozione, ragione, cervello umano. Ed. Adelphi, Milano, 1995.
29. De Renzi E.: Le amnesie. In: Bisiach, Denes, De Renzi et al.: Neuropsicologia clinica. Franco Angeli Editore, Milano, 1977; 199-246.
30. Deakin J.F.W.: Three distinct roles of 5-ht in anxiety, panic and depression. In: Montgomery SA, Corn T.H. (eds.): Psychopharmacology of depression. Oxford University Press, 1994; 87-101,
31. Diamond P.T., Holroyd S., Macciocchi S.N., Felsenthal G.: Prevalence of depression and outcome on the geriatric rehabilitation unit. Am. J. Phys. Med. Rehabil., 1995; 3: 214-217.
32. Dierick M.: An open-label evaluation of the long-term safety of oral venlafaxine in depressed elderly patients. Ann. Clin. Psychiatry, 1996; 8: 169-178.
33. Diller L., Bishop D.S.: Depression and stroke. Top Stroke Rehabilitation, 1995; 2(2): 44-45.
34. Downhill J.E., Robimson R.G.: Longitudinal assessment of depression and cognitive impairment following stroke. J. Nerv. Ment. Dis., 1994; 182(8): 425-431.
35. Dromerik A., Reding M.: Medical and neurological complications during inpatients stroke rehabilitation; Stroke, 1994; 2: 58-61.
36. Eastwood M.R., Rifat S.L., Nobbis H., Ruderman J.: Mood disorders following cerebrovascular accident. Br. J. Psychiatry, 1989; 154: 195-200.
37. Ebrahim S., Barer K.D., Nouti F.: Affective illness after stroke. Br. J. Psychiatry, 1987; 151: 52-60.
38. Everton S.A., et al.: Arch. Intern. Med., 1998; 158: 1133-1138.
39. Farha M.: The neural bases of Mental Imagery. In: Cazzaniga M.S. (ed.). The Cognitive Neurosciences. The MIT Press, Cambridge; 1994.
40. Feighner J.P.: The role of venlafaxina in rational antidepressant therapy. J. Clin. Psychiatry, 1994; 55 (9, suppl. A): 62-68.
41. Finklestein S.P., Weintraub R.J., Karmouz N., Askinazi C., Davar G., Baldessarini R.J.: Anti-depressant drug treatment for post-stroke depression: a retrospective study. Arch. Phys. Med. Rehabil., 1987; 68: 772-776.
42. Fuster J.M.: Network memory. Trends Neurosci., 1997; 20, 10: 451-459.
43. Gevins A.: The future of EEG in assessing neurocognitive functioning. Electroencephalogr. Clin. Neurophysiol., 1998; 106 (2): 165-172.
44. Goldstein L.B., Bartels C., Davis J.N.: Interrater reliability of the NIH stroke scale. Arch. Neurol., 1989; 46: 660-662.
45. Gordon J.: Assumption underlying physical therapy intervention: theoretical and historical perspectives. In: Carr J., et al. (eds.). Movement science foundations for physical therapy in rehabilitation. Aspen Publishers Inc., Rockville (MD), 1987; 1-30.
46. Gordon W.A.: Treatment of affective deficits in stroke rehabilitation. Final report, National Institutes of Health; NS 24608; 1992.
47. Gordon W.A.: Post-stroke depression: an examination of the literature. Arch. Phys. Med. Rehabil., 1997; 18, 658-663.
48. Gordon W.A., Diller R.: Stroke: coping with a cognitive deficit. In: Burisch E., Bradley L. A. (Eds.) Coping with chronic disease: research and applications. New York Academic Press, 1983; 113-135.
49. Graeff F.G., Guimaraes F.S., De Andrade T.C., Deakin J.F.: Role of 5HT in stress, anxiety, and depression. Pharmacol. Biochem. Behav., 1996; 54: 129-141.
50. Grafton T., Hazeltine E., Ivry R.: Functional mapping of sequence learning in normal humans. Journal of Cognitive Neuroscience, 1995; 7 (4): 497-510.
51. Gresham G.E., Phillips T.F., et al.: Epidemiologic profile of long-term stroke disability: the Framingham study. Arch. Phys. Med. Rehabil., 1979; 60(11): 487-491.
52. Grober S., Hibbard M.R., Gordon W.A.: The psychotherapeutic treatment of post-stroke depression with cognitive, behavioral therapy. In: Gordon W.A. (ed.). Advances in stroke rehabilitation. Andove Medical Publishers, 1993; 217-241.
53. Haley E.G., Brett T.G., Sheppard G.L., et al.: Pilot randomized trial of tissue plasminogen activator in acute ischemic stroke. Stroke, 1993; 24: 1000-1004.
54. Hamilton M.: Development of a rating scale for primary depressive illness.; Br. J. Soc.Clin. Psychol., 1967; 6: 278-296.
55. Hermann M., Bartels C., Schumaker M., Wallesch CW.: Post-stroke depression: is there a pathoanatomic correlate for depression in the postacute stage of stroke? Stroke, 1995; 5: 850-856.
56. Herndon R.M.: Handbook of Neurologic Rating Scales. Demos Vernande, New York, USA, 1997.
57. Holliday S.M., Benfield P.: Venlafaxine: a review of its pharmacology and therapeutic potential in depression. Drugs, 1995; 49 (2): 280-294.
58. Hoofien D.: La riabilitazione dell'attenzione. In: Mazzucchi A. (Ed.). La riabilitazione neuropsicologica. Ed. Il Mulino, Bologna, 1987.
59. Houghton G., Tipper S.P.: Inhibitory mechanism of neural and cognitive control: applications to selective attention and sequential action. Brain Cogn., 1996; 30: 20-43.
60. House A., Dennis M., Morgridge L., Warlow C.: Mood disorders in the year after first stroke. Br. J. Psychiatry, 1991; 158: 83-89.
61. House A., Dennis M., Warlow C.: The relationship between intellectual impairment and mood disorder in the first year after stroke. Psychol. Med., 1990; 20: 805-814.
62. Jonides J., Smith E., Koeppe R.A., Awh E., Minoshima S.: Spatial working memory in human revealed by PET. Nature, 1993; 363: 623-624.
63. Khan A., Rudolf R., Baumel B., Ferguson J.M., Ryan P., Shrivastava R.: Venlafaxine in depressed geriatric outpatients. Psychopharmacol. Bull., 1995; 31: 753-758.
64. Koivisto K., Viinamaki H., Reikkinen P.: Poststroke depression and rehabilitation outcome. Nord J. Pychiatry 1993; 47: 245-249.
65. Kosslyn S.M., Alpert N.M., Thompson W.L., et al.: Visual mental imagery activates topographically organized visual cortex. PET investigations. Journal of Cognitive Neuroscience, 1993; 5: 263-267.
66. Kosslyn S.M., et al.: Roles of imagery in perception: or, there is no such thing as immaculate perception. In: Gazzaniga M.S. (ed.). Cognitive Neuroscience: The biology of the mind. WW Norton & Co., New York, 1995; 1035-1042.
67. Labi M.L.C., Phillips T.F., Gresham G.E.: Psychosocial disability in physically restored long-term stroke survivors. Arch. Phys. Med. Rehabil., 1980; 61: 561-565.
68. Ledoux J.: In search of an emotional system in the brain. In: Cazzaniga M.S. (Ed.) The Cognitive Neurosciences. The MIT Press, Cambridge, 1994.
69. Linden M., Borchelt M, Barnow S., Geiselmann B.: The impact of somatic morbidity on the Hamilton Depression Rating Scale in the very old. Acta Psychiatr. Scand., 1995; 92: 150-154.
70. Logsdon R., Teri L.: Depression in Alzheimer's disease patients: caregivers as surrogate reporters. J. Am. Geriatr. Soc., 1955; 43:150-155.
71. Lyden P., Brott T., Tilley B., Welch KMA, Maascha EJ: NINDS TPA Stroke Study Group. Improved reliability of the NIH stroke scale using video training. Stroke, 1994; 25: 2220-2226.
72. Lyness J.M., Caine E.D.: Depressive symptoms, medical illness and functional status in depressed psychiatric inpatiens. Am. J. Psychiatry, 1993; 150: 910-915.
73. Magni G., Hackett D.: An open-label evaluation of the long-term safety and clinical acceptability of venlafaxyne in depressed patients. Clin. Neuropharmacol., 1992; 15 (suppl. 1, pt B): 323.
74. McCarty R.A., Warrington E.K.: Neuropsicologia cognitiva, Milano, 1992.
75. MacHale S.M., O'Rourke S.J., Wardlaw J.M., Dennis M.S.: Depression and its relation to lesion location after stroke. Neurol. Neurosurg. Psychiatry, 1998; 64: 371-374.
76. Mayberg H.S., Robinson R.G., Wong D.F.: PET imaging of cortical S2-serotonin receptors following stroke: lateralized changes and relationship to depression. Am. J. Psychiatry, 1988; 145: 937-943.
77. Morris P.L., Robinson R.G., Raphael B.: Prevalence and course of depressive disorders in hospitalized stroke patients. Int. J. Psychiatry Med., 1990; 20 (4): 349-364.
78. Morris P.L., Robinson R.G., Andrzejewski P.: Association of depression with 10-year poststroke mortality. Am. J. Psychiatry, 1993; 150: 124-129.
79. Morrison J.H., Molliver M.E., Gzranna R.: Noradrenergic innervation of the cerebral cortex: widespread effects of local cortical lesions. Science, 1979; 205: 313-316.
80. Murray G.B. Shea V.M., Conn D.K.: Electroconvulsive therapy for post-stroke depressed geriatric patients. J. Neuropsychiatry Clin. Neurosci., 1986; 47: 258-260.
81. Ng K.G., Chan K.L.: A study of post-stroke depression in a rehabilitative center. Acta Psychiatr. Scand., 1995; 92: 75-79.
82. Neisser U.: Conoscenza e realtà. Ed. il Mulino, Bologna, 1993.
83. Nierenberg A.A., Feighner J.P., Rudolph R., Cole J.O., Sullivan J.: Venlafaxyne for treatment-resistant depression. J Clin. Psycopharmacol., 1994; 14: 419-423.
84. Olsson T., Asplund K.: Different linkage of depression to hypercortisolism early versus late after stroke. A 3-year longitudinal study. Stroke, 1993; 24:52-57.
85. Pancheri P.: Terapia del disturbo di panico. Ed. Scientific Press, Firenze, 1997.
86. Parikh R.M., Robinson R.G., Lipsey J.R.: The impact of post-stroke depression on recovery in activities of daily living over a two-year follow-up. Arch. Neurol., 1990; 47: 785-789.
87. Pascual-Leone A., Torres F.: Plasticity of the sensorimotor cortex representation of the reading finger in Braille readers. Brain, 1993; 116: 39-52.
88. Pearlson G.D., Robinson R.G.: Suction lesions of the frontal cerebral cortex in the rat induce asymmetrical behavioral and catecholaminergic responses. Brain Res., 1981; 218: 233-242.
89. Pecknold J.C.: Serotonin abnormalities in panic disorders. In: Ballenger J.C. (ed): Neurobiology of panic disorder. Wiley-Liss, NewYork, 1990.
90. Pelliccioli G.P., Presciutti O., Floridi P., Campanella S., Chiarini P., Zampolini M.: La risonanza magnetica funzionale nello studio della riorganizzazione plastica cerebrale post-ictale. Rivista di Neuroradiologia, 1997; 10 (suppl. 2): 31-38.
91. Perfetti C., Rossetto F.: L'immagine motoria come elemento dell'esercizio terapeutico conoscitivo. Riabilitazione e Apprendimento, G. Gnocchi Editore 2: 1997: 109-115.
92. Perret A.: The left frontal lobe of man and suppression of habitual responses in verbal categorical behaviour. Neuropsycologia, 1974; 12: 323-330.
93. Peter B.J., Wu M.D.: Post-stroke depression. California Resident Advancement Council in PM&R, 1996.
94. Petrides M., Alivisatos B., Evans A.C., Meyer E.: Dissociation of human mid-dorsolateral from posterior dorsolateral frontal cortex in memory processing. Proceedings of the National Academy of Science USA, 1993; 90: 873-877.
95. Ramasubbu R., Kennedy S.H.: Factor complicating the diagnosis of depression in cerebrovascular disease. Can. J. Psychiatry, 1995; 39 (10): 596-607.
96. Reis D.J., Ross R.A.: Dynamic changes in brain dopamine B-hydroxylase activity during anterograde and retrograde reactions to injury of central noradrenergic axons. Brain Res., 1973; 57: 307-326.
97. Riedel G.: Function of metabotropic glutamate receptors in learning and memory. 1996; 19: 219-224.
98. Robinson R.G., Benson D.F.: Depression in aphasic patients: frequency, severity and clinical-pathological correlations. Brain Lang., 1981; 14(2): 282-291.
99. Robinson R.G., Price T.R.: Post-stroke depressive disorders: a follow-up study of 103 patients. Stroke, 1982; 13(5): 635-664.
100. Robinson R.G., Starr L.B. Kubos K.L., Price T.R.: A two years longitudinal study of post-stroke mood disorders: findings during the initial evaluation. Stroke, 1983; 14(5): 736-744.
101. Robinson R.G., Starr L.B. Kubos K.L., Price T.R.: Mood disorders in stroke patients: importance of localization of lesion. Brain, 1984; 107, 81-93.
102. Robinson R.G., Bolduc P.L., Price T.R.: A two year longitudinal study of post-stroke mood disorders: diagnosis and outcome at one and two years. Stroke, 1987; 18(5): 837-843.
103. Robinson R.G., Parick R.M., Lipsey J.R., Starkstein S.E., Price T.R.: Pathological laughing and crying following stroke: validation of a measurement scale and a double-blind-study. Am. J. Psychiatry, 1993; 150: 286-293.
104. Roncaglioni C., Bertelè V.: L'ictus ed il danno ischemico cerebrale. Scienze ADV, Milano, 1996.
105. Roth M.: Categorical sub-types and dimension of illness in the anxiety and related disorders, in Noyes R. Jr., Roth M, Burrows GD (eds). Classification, etiological factors and associated disturbances. Handbook of anxiety, Vol. 2. Elsevier, Amsterdam, 1988.
106. Rozzini R., Trabucchi M.: La depressione dell'anziano. Torino, Ed. UTET, 1996.
107. Rudolph R., Entsuah R., Derivan A.: Early clinical response in depression to venlafaxine hydrochloride. Biol Psychiatry, 1991; 29: 630.
108. Samuelian J.C., Tatossian A., Hackett D.: A randomized, double-blind comparison of venlafaxine and clomipramine in outpatients with major depression; Clin. Neuropharmacol, 1992; 15 (suppl. 1, pt B): 324.
109. Schwartz J.A., Speed N.M., Brunberg J.A., Brewer T.L.: Depression in stroke rehabilitation. Biol. Psychiatry, 1993; 10: 694-699.
110. Schweitzer E., Feighner J., Mandos L.A.: Comparison of venlafaxine and clomipramine in the acute treatment of major depression in outpatients. J. Clin. Psychiatry, 1994; 55: 104-108.
111. Sharpe M., Hawton K., Seagroat V.: Depressive disorders in long-term survivors of stroke. Br. J. Psychiatry, 1994; 160: 380-386.
112. Shinar D., Gross C.R., Bronstein K.S., et al: Reliability of the activities of daily living scale and its use in the telephone interview. Arch. Phys. Med. Rehabil., 1987; 68: 723-728.
113. Shrivastave R.K., Chon C., Crowder J.: Long-term safety and clinical acceptability of venlafaxine and imipramine in outpatients with major depression. J. Clin. Psychopharmacology, 1994; 14: 322-329.
114. Spinnler H., G. Tognoni (Eds.): Standardizzazione e taratura Italiana di test neuropsicologici. Ital. J. Neurol. Sci. 1987; 6 (suppl. 8).
115. Squire L., Knowlton B.: Memory, hippocampus and brain systems. In: Cazzaniga M.S. (Ed.). The Cognitive Neurosciences. The MIT Press, Cambridge, 1994.
116. Stadler M.A.: The role of attention in implicit learning. Journal of Experimental Psychology: Learning and Memory Cognition, 1995: 1.
117. Starkstein S.E., Robinson R.G.: Affective Disorders and Cerebral Vascular Disease. Br. J. Psychiatry, 1989; 154: 170-182.
118. Torta R.: Depressione e stroke. Mediserve, Milano, 1994.
119. Torta R., Cicolin A., Keller R.: Stroke and depression: clinical features and treatment. Ital. J. Neurol Sci., 1998; 19: s20-s24.
120. Varela F.J.: Un know how per l'etica. Ed. Laterza, Roma, 1992.
121. Wade D.T., Hewer R.L. Functional abilities after stroke: measurement, natural history and prognosis. J. Neurol. Neurosurg. Psychiatry. 1987; 50: 177-182.
122. Wade D.T., Legh-Smith J., Hewer R.A.: Depressed mood after stroke. A community study of its frequency. Br. J. Psychiatry, 1987; 151: 200-205.
123. Wayne A., Gordon D., Mary R., Hibbard D.: Poststroke depression: An examination of the literature. Arch. Phys. Med. Rehabil., 1997; 78: 658-663.
124. Wilson B.: La riabilitazione dei disturbi della memoria. In: Mazzucchi A. (Ed.). La riabilitazione neuropsicologica. Il Mulino, Bologna, 1987.
125. Wilson F.A., Scalaidhe P.O., Goldman-Rakic P.S.: Dissociation of object and spatial processing domains in primate prefrontal cortex. Science, 1993; 260: 1955-1958.
126. Yamaguchi S., Kobayaschi S., Koide H., Tsunematsu T.: Longitudinal study of regional cerebral blood flow changes in depression after stroke. Stroke, 1992; 23: 1716-1722.
127. Yesavage J., Brink T., Rose T.: Development and validation of a geriatric depression screening scale: a preliminary report. Psychiatric Res., 1983: 17:37-49.
128. Yue G., Cole K.J.: Strength increases from the motor program: comparison of training with maximal voluntary and imagined muscle contractions. J. Neurophysiol., 1992; 67: 1114-1123.